1. Home
  2. FRME vs AMPH Comparison

FRME vs AMPH Comparison

Compare FRME & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Merchants Corporation

FRME

First Merchants Corporation

HOLD

Current Price

$38.24

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.63

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRME
AMPH
Founded
1893
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FRME
AMPH
Price
$38.24
$26.63
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$47.33
$31.00
AVG Volume (30 Days)
285.1K
396.5K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
3.75%
N/A
EPS Growth
32.99
N/A
EPS
4.00
2.27
Revenue
$649,589,000.00
$723,305,000.00
Revenue This Year
$13.83
$1.35
Revenue Next Year
$14.54
$5.10
P/E Ratio
$9.58
$11.72
Revenue Growth
9.53
N/A
52 Week Low
$33.13
$20.39
52 Week High
$45.62
$40.74

Technical Indicators

Market Signals
Indicator
FRME
AMPH
Relative Strength Index (RSI) 56.27 53.43
Support Level $38.71 $25.16
Resistance Level $39.38 $26.50
Average True Range (ATR) 0.74 0.87
MACD 0.10 -0.04
Stochastic Oscillator 56.52 54.88

Price Performance

Historical Comparison
FRME
AMPH

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: